Physical Access Control System

Added: Jun 09, 2015 5:13 pm 1 Introduction
This is a Request for Information (RFI) issued by the U.S. Food and Drug Administration (FDA or Agency), Office of Operations (OO). This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this RFI is to obtain technical information regarding physical access control systems (PACS) that will enable FDA to replace and modernize its existing access control system deployed across roughly 100 facilities nationwide.

2 Project Description

2.1 Background
The FDA is charged with protecting the public health by ensuring the safety, effectiveness, and security of human and veterinary drugs, biological products, and medical devices; ensuring the safety of foods, cosmetics, and radiation-emitting products; and regulating tobacco products. The Agency consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations. The total FDA workforce is over 17,000, representing about 15,000 FTE (12,000 at Headquarters and 3,000 in the field).

The Office of Operations is responsible for ensuring the timely and effective delivery of high quality and cost effective mission support services across the FDA and its Centers, and coordinating emergency preparedness and response activities for incidents involving FDA-regulated products across FDA and its stakeholders. The mission support services include equal employment, facilities and mission support services, finance, human resources, information technology management and security operations. The Office of Security Operations (OSO), a component of OO, is staffed with approximately 40 staff to include employees, contractors and students. OSO creates a high quality work environment by administering the physical and personnel security programs and contributing to the Agency's mission of protecting the public health by enhancing the safety and security of all personnel, facilities and information.

The FDA headquarters and the concentration of its staff are primarily at the White Oak campus located in Silver Spring, Maryland at 10903 New Hampshire Avenue. FDA also has headquarters staff located throughout the Washington DC metropolitan area and field staff nationwide.

2.2 Purpose
The purpose of this RFI is to invite responses that will assist FDA in understanding the products and services typically offered by entities that provide PACS solutions. FDA will not award a contract on the basis of the responses to this RFI.

The following background information is provided for the current infrastructure:

Number of employees 17,000
Number of active PIV badge holders 30,000
Number of controlled facilities 100
Number of enclosures/panels 230
Number of badge readers (including PIV and some biometric readers 2,350

2.3 Requirements
The PACS solution shall replace existing system functionality as well as, in some cases, add system functionality where none existed previously.
The PACS solution should meet, but not be limited to, the following categories of requirements:
• Basic system operation (e.g., electronic locks, card readers, intrusion detection systems, alarm management systems)
• System features, including:
o Administration (e.g., user configurable disposition entries, guard tour capability)
o Authorization (e.g., two man arming with keypads, elevator control)
o Authentication (e.g., biometrics support, quick view dossier on cardholder data)
o Audit (e.g., complete audit trails)
• Compliance-related requirements (e.g., FISMA, FIPS, FICAM, path to APL-2 certification)

3 Response Requested

3.1 Information Sought
The attached document requests responses from any person or entity (Respondents). Respondents shall prepare their responses using the attached form. Responses are to be clear, concise, and directly address the questions.

4 Response Preparation and Submission

4.1 How to Enter Information
Type information in the white text fields on the provided RFI Form. If the information requested does not apply to the Respondent's situation, then enter "N/A" into the text field. Please enter the requested information or N/A into every text field.

Responses must be in MS Word or PDF format.

4.2 Request for Information Contact
The individual listed below shall be the single point of contact for this RFI. Unless otherwise directed, Respondent should only communicate with the RFI Contact. The FDA shall not be held responsible for information provided by or to any other person.

RFI Contact Phillip Frame
Email Phillip.Frame@fda.hhs.gov

Do not discuss this RFI, directly or indirectly, with any FDA employee other than the RFI Contact.

4.3 Submission Deadline
Submission details are provided below.
Due Date June 24, 2015
Time 2:00 pm, ET
Delivery Email

This RFI is being issued solely for the purpose of gaining knowledge that will assist FDA in understanding products and services typically offered by entities that provide PACS solutions. This RFI is not a solicitation and no contract will result from any response to this RFI by any Respondent. The FDA will not pay for any information requested in this RFI, nor is the FDA liable for any costs incurred by any Respondent.

The responses to this RFI should be submitted on the form provided in this notice. Respondents are cautioned that all information provided in response to this RFI is considered the property of the FDA and will be available for public review. As a public body subject to laws requiring openness and transparency (e.g., the Freedom of Information Act), FDA cannot guarantee that any information submitted pursuant to this RFI will be protected from public disclosure. Respondents are encouraged to provide detailed responses to the questions; however, Respondents may choose to leave questions unanswered.

Submitting a response or declining to respond to this RFI will not preclude a Respondent from responding to future postings, if any, with regards to this requirement.